SCHEMBL7349908

SCHEMBL7349908

O=C(N[C@@H](Cc1ccccc1)C(=O)CSCc1ccco1)c1cc(=O)c2ccccc2o1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 4/20 0.61
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
THRB P10828 1/20 0.44
CSNK2A2 P19784 5/20 0.42
CSNK2B P67870 5/20 0.42
CSNK2A1 P68400 5/20 0.42
CSNK2A3 Q8NEV1 5/20 0.42
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
KDM4E B2RXH2 1/20 0.41
USP2 O75604 1/20 0.41
PTGS1 P23219 1/20 0.41
MAOB P27338 2/20 0.40
RECQL P46063 1/20 0.40
MAOA P21397 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7349928 1.00 CAPN1 (0.61) CAPN1LMNAPOLBMAPTTHRB
SCHEMBL7312803 0.93 CAPN1 (0.53) CAPN1LMNAPOLBMAPTTHRB
SCHEMBL7312816 0.93 CAPN1 (0.53) CAPN1LMNAPOLBMAPTTHRB
SCHEMBL7348921 0.88 RAB9A (0.53) CAPN1LMNAPOLBMAPTTHRB
SCHEMBL7305250 0.82 TAS1R3 (0.52) CAPN1LMNATHRBMEN1NPC1
SCHEMBL8885687 0.81 CAPN1 (0.42) CAPN1LMNAPOLBMAPTTHRB
SCHEMBL8885698 0.81 CAPN1 (0.42) CAPN1LMNAPOLBMAPTTHRB
SCHEMBL7342545 0.79 PSMB5 (0.47) POLBMAPTNPC1RAB9AKMT2A
SCHEMBL7342540 0.79 PSMB5 (0.47) POLBMAPTNPC1RAB9AKMT2A
SCHEMBL7343844 0.79 HPGD (0.53) POLBMAPTMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0603873-B1 Aminoketone derivatives MITSUBISHI CHEM CORP (JP) 1998-04-15 EP disclosed
US-5424325-A Inibitors of thiol protease and may be used as therapeutic agents for treating muscular dystrophy, cataracts, strokes MITSUBISHI KASEI CORPORATION (JP) 1995-06-13 US disclosed
EP-0603873-A1 Aminoketone derivatives Mitsubishi Chemical Corporation (JP) 1994-06-29 EP disclosed